BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17726264)

  • 1. Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
    Fleischmann A; Waser B; Reubi JC
    Cell Oncol; 2007; 29(5):421-33. PubMed ID: 17726264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
    Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
    Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
    Fleischmann A; Waser B; Reubi JC
    Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.
    Reubi JC; Fleischmann A; Waser B; Rehmann R
    Peptides; 2011 Jul; 32(7):1457-62. PubMed ID: 21605611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast.
    Gugger M; Reubi JC
    Am J Pathol; 1999 Dec; 155(6):2067-76. PubMed ID: 10595936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers.
    Sun B; Schally AV; Halmos G
    Regul Pept; 2000 Jun; 90(1-3):77-84. PubMed ID: 10828496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments.
    Fleischmann A; Waser B; Gebbers JO; Reubi JC
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4722-9. PubMed ID: 15941862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
    Markwalder R; Reubi JC
    Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
    Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
    Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.
    Waser B; Eltschinger V; Linder K; Nunn A; Reubi JC
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):95-100. PubMed ID: 16909223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma.
    Pansky A; DE Weerth A; Fasler-Kan E; Boulay JL; Schulz M; Ketterer S; Selck C; Beglinger C; VON Schrenck T; Hildebrand P
    J Am Soc Nephrol; 2000 Aug; 11(8):1409-1418. PubMed ID: 10906154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bombesin receptors in distinct tissue compartments of human pancreatic diseases.
    Fleischmann A; Läderach U; Friess H; Buechler MW; Reubi JC
    Lab Invest; 2000 Dec; 80(12):1807-17. PubMed ID: 11140694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
    de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
    J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
    J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.
    Thomas R; Chen J; Roudier MM; Vessella RL; Lantry LE; Nunn AD
    Clin Exp Metastasis; 2009; 26(2):105-19. PubMed ID: 18975117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G; Wittliff JL; Schally AV
    Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.